Nanalysis Scientific Corp.
NSCIF
$0.1854
-$0.0009-0.48%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.38M | 8.78M | 7.75M | 8.39M | 8.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.38M | 8.78M | 7.75M | 8.39M | 8.28M |
| Cost of Revenue | 5.49M | 5.79M | 5.56M | 6.04M | 6.53M |
| Gross Profit | 1.89M | 2.99M | 2.19M | 2.35M | 1.75M |
| SG&A Expenses | 1.94M | 1.90M | 2.05M | 2.32M | 1.98M |
| Depreciation & Amortization | 598.50K | 775.80K | 805.00K | 792.90K | 804.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.12M | 8.54M | 8.49M | 9.16M | 9.54M |
| Operating Income | -742.10K | 239.30K | -744.20K | -773.90K | -1.27M |
| Income Before Tax | -873.80K | -5.34M | -1.20M | -1.46M | -1.86M |
| Income Tax Expenses | 36.90K | -19.30K | 2.20K | -4.40K | 5.90K |
| Earnings from Continuing Operations | -910.70K | -5.32M | -1.21M | -1.46M | -1.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -910.70K | -5.32M | -1.21M | -1.46M | -1.87M |
| EBIT | -742.10K | 239.30K | -744.20K | -773.90K | -1.27M |
| EBITDA | -622.20K | 421.50K | -552.80K | -585.40K | -410.90K |
| EPS Basic | -0.01 | -0.05 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.05 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 113.22M | 113.13M | 113.10M | 113.03M | 103.26M |
| Average Diluted Shares Outstanding | 113.22M | 113.13M | 113.10M | 113.03M | 103.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |